Trulieve CEO: Clinical Hashish Transition | Inflamed Money | CNBC

Trulieve CEO: Clinical Hashish Transition | Inflamed Money | CNBC

It’s a clinical marijuana firm serving to over 80,000 patients and that you just would be in a position to well even fetch never heard of it. Jim Cramer looks…